Long-term study of glaucoma surgeries and lasers
Part of Eyes & vision clinical trials.
This study follows patients over time to see how well different glaucoma treatments (medications, laser, or surgery) work. It may help doctors learn which treatments are best for managing glaucoma and high eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glaucoma (any type) or high eye pressure (above 24 mmHg).
- You are 18 years old or older.
- You have received treatment (medication, laser, or surgery) at the Glaucoma Centre, Montchoisi Clinic or Swiss Visio Montchoisi.
- You understand the study and can give your consent to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.
This trial tests how well a laser treatment called selective laser trabeculoplasty works in people with open-angle glaucoma. It looks at results over 12 months to see if it helps lower eye pressure.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This study follows people with glaucoma, higher-than-normal eye pressure, or a suspected risk of glaucoma. It aims to better understand how eye pressure and eye findings relate to glaucoma and may guide future treatment decisions.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.